Products
Signal Tracker Data Platform Data Enrichment API Intelligence deskSolutions
Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For InvestorsExplore
Companies Live Signals Markets TrendsResources
Signal Checker Blog Integrations FAQ Contact Pricing
The de-extinction company
Dallas, United States
252 employees
Total: $610.00M
Biotechnology
Dallas, United States
BounceWatch is an independent company data service, not affiliated with Colossal Biosciences. To contact Colossal Biosciences, visit colossal.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
United States Market
Biotechnology
Colossal Biosciences is a bioscience and genetic engineering company based in Dallas, United States. It focuses on developing technologies for genomics and the restoration of extinct species.
Founded in 2021, Colossal Biosciences specializes in species restoration and endangered species protection. The company utilizes CRISPR technology and genomic engineering to support ecosystem conservation. It does not have a specified business or revenue model.
Taxonomy: Genetics, Bioscience, Genomic engineering, CRISPR technology, De-extinction, Species restoration, Endangered species protection, Ecosystem conservation, Biological engineering, Environmental restoration, Disruptive technologies, Biological innovation, Sustainable development, Genetic research, Conservation biology
| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Angel | $120.00M | 2 |
|
01 Sep 2025 |
| Series C | $200.00M | 1 |
TWG Global
|
01 Jan 2025 |
| Late VC | $50.00M | - |
|
01 Oct 2024 |
| Series B | Undisclosed | - |
|
01 Jul 2023 |
| Series B | $150.00M | 11 |
|
01 Jan 2023 |
| Early VC | Undisclosed | 1 |
|
01 Oct 2022 |
| Series A | $60.00M | 15 |
|
01 Mar 2022 |
| Seed | $15.00M | 16 |
|
01 Sep 2021 |
| Seed | $15.00M | 6 |
|
01 May 2021 |
| Corporate Spinout | Undisclosed | 1 |
Form Bio
|
01 Jan 2021 |
The future of genetic medicine is epic.
Source: BounceWatch company record for Colossal Biosciences, https://bouncewatch.com/company/colossal-biosciences, updated 29 September 2026. When citing, please name BounceWatch and link this page.
Analytics cookies (ours + Google). We use analytics cookies (our own and Google Analytics) to understand how the site is used. Essential cookies are always on. You decide on analytics. Cookie Policy
